Immuron (NASDAQ:IMRN) Stock, Quote.Headers.trade-ideas

Immuron

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

VFCorp.Shutterstock

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AMKR

AREB

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DBGI

EVOK

FFIV

GRDI

HLIT

HRYU

IMRN

IVDA

LIXT

LTBR

QUBT

SHPH

TMDX

VEEA

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

Intraday Update

ACOR

ADIL

ASTI

BNRG

BPTS

BSGM

CISS

DCGO

DECK

DOGZ

DXYZ

EZGO

GRRR

ICCT

IFBD

JAGX

KITT

MGAM

MRIN

MRNO

NEOV

NOVA

NUTX

OPEN

PRFX

RETO

RVMD

TSLA

VERB

VIAO

VINO

Shares of  Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share.

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

GLMD

INAB

MSFT

PSMT

SLNA

Shares of  PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

Press Releases

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Health Care

Immuron Announces Travelan® Clinical Trial Update

Financing

Analyst Ratings

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

General

Immuron Travelan® continued strong sales growth

Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Immuron Travelan® highest sales in history

Immuron Letter to Shareholders: Projects Update

AEMD

ANPCY

ASPI

ATWT

BDRX

BENF

BIXT

BOSC

CSE:HG

ELRRF

GOSS

GOVX

HDRSF

HGRAF

IPWR

LGVN

MESO

PBEGF

RGBP

SIGY

TSX:CNL

TSX:ELO

TSX:TXP

TSXV:HI

TSXV:WRLG

UCAR

USEG

WRLGF

XXII

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Aprea Therapeutics

Aptevo Therapeutics

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

CEL-SCI

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Equillium

Genprex

Geovax Labs

HCW Biologics

Immuron Limited - American Depositary Shares

Kairos Pharma

Mustang Bio

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

BiomX

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics

TAO Synergies

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Turnstone Biologics

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Litchfield Hills

Comments

Immuron

Immuron (NASDAQ:IMRN) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell